152 related articles for article (PubMed ID: 37985353)
1. A promising prognostic grading system incorporating weight loss and inflammation in patients with advanced cancer.
Zhang X; Huang JX; Tang M; Zhang Q; Deng L; Song CH; Li W; Shi HP; Cong MH
J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2969-2980. PubMed ID: 37985353
[TBL] [Abstract][Full Text] [Related]
2. The relationship between the BMI-adjusted weight loss grading system and quality of life in patients with incurable cancer.
Daly L; Dolan R; Power D; Ní Bhuachalla É; Sim W; Fallon M; Cushen S; Simmons C; McMillan DC; Laird BJ; Ryan A
J Cachexia Sarcopenia Muscle; 2020 Feb; 11(1):160-168. PubMed ID: 31692296
[TBL] [Abstract][Full Text] [Related]
3. Association between a novel nutrition-inflammation prognostic grading system and overall survival in hospitalized adults with cancer: A retrospective cohort study.
Huang JX; Zhang X; Tang M; Zhang Q; Deng L; Song CH; Li W; Yang M; Shi HP; Cong MH
JPEN J Parenter Enteral Nutr; 2024 Jan; 48(1):108-119. PubMed ID: 37855392
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic criteria for the classification of cancer-associated weight loss.
Martin L; Senesse P; Gioulbasanis I; Antoun S; Bozzetti F; Deans C; Strasser F; Thoresen L; Jagoe RT; Chasen M; Lundholm K; Bosaeus I; Fearon KH; Baracos VE
J Clin Oncol; 2015 Jan; 33(1):90-9. PubMed ID: 25422490
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive analysis of the association between anemia and systemic inflammation in older patients with cancer.
Zhang X; Huang JX; Tang M; Zhang Q; Deng L; Song CH; Li W; Yang M; Shi HP; Cong MH
Support Care Cancer; 2023 Dec; 32(1):39. PubMed ID: 38110562
[TBL] [Abstract][Full Text] [Related]
6. Individualized threshold of the involuntary weight loss in prognostic assessment of cancer.
Xie H; Zhang H; Ruan G; Wei L; Ge Y; Lin S; Song M; Wang Z; Liu C; Shi J; Liu X; Yang M; Zheng X; Chen Y; Zhang X; Shi H
J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2948-2958. PubMed ID: 37994288
[TBL] [Abstract][Full Text] [Related]
7. Association of nutrition parameters including bioelectrical impedance and systemic inflammatory response with quality of life and prognosis in patients with advanced non-small-cell lung cancer: a prospective study.
Sánchez-Lara K; Turcott JG; Juárez E; Guevara P; Núñez-Valencia C; Oñate-Ocaña LF; Flores D; Arrieta O
Nutr Cancer; 2012; 64(4):526-34. PubMed ID: 22489794
[TBL] [Abstract][Full Text] [Related]
8. Association of Weight Change, Inflammation Markers and Disease Staging with Survival of Patients Undergoing Chemotherapy for Pancreatic Adenocarcinoma.
Vasconcelos de Matos L; Coelho A; Cunha R; Fernandes L; Fontes E Sousa M; Neves MT; Cardoso D; Malheiro M; Graça J; Santos Silva E; Plácido A; Martins A
Nutr Cancer; 2022; 74(2):546-554. PubMed ID: 33749421
[TBL] [Abstract][Full Text] [Related]
9. Scored-GLIM as an effective tool to assess nutrition status and predict survival in patients with cancer.
Zhang Q; Zhang KP; Zhang X; Tang M; Song CH; Cong MH; Guo ZQ; Ding JS; Braga M; Cederholm T; Xu HX; Li W; Barazzoni R; Shi HP
Clin Nutr; 2021 Jun; 40(6):4225-4233. PubMed ID: 33579553
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and prognostic significance of malnutrition in patients with cancers of the head and neck.
Kubrak C; Martin L; Gramlich L; Scrimger R; Jha N; Debenham B; Chua N; Walker J; Baracos VE
Clin Nutr; 2020 Mar; 39(3):901-909. PubMed ID: 31000341
[TBL] [Abstract][Full Text] [Related]
11. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
[TBL] [Abstract][Full Text] [Related]
12. Impact of weight loss in patients with heart failure with preserved ejection fraction: results from the FLAGSHIP study.
Kamisaka K; Kamiya K; Iwatsu K; Iritani N; Imoto S; Adachi T; Iida Y; Yamada S;
ESC Heart Fail; 2021 Dec; 8(6):5293-5303. PubMed ID: 34599855
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil-Lymphocyte Ratio Is a Prognostic Marker in Patients with Locally Advanced (Stage IIIA and IIIB) Non-Small Cell Lung Cancer Treated with Combined Modality Therapy.
Scilla KA; Bentzen SM; Lam VK; Mohindra P; Nichols EM; Vyfhuis MA; Bhooshan N; Feigenberg SJ; Edelman MJ; Feliciano JL
Oncologist; 2017 Jun; 22(6):737-742. PubMed ID: 28533476
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic criteria for cancer cachexia: reduced food intake and inflammation predict weight loss and survival in an international, multi-cohort analysis.
Martin L; Muscaritoli M; Bourdel-Marchasson I; Kubrak C; Laird B; Gagnon B; Chasen M; Gioulbasanis I; Wallengren O; Voss AC; Goldwasser F; Jagoe RT; Deans C; Bozzetti F; Strasser F; Thoresen L; Kazemi S; Baracos V; Senesse P
J Cachexia Sarcopenia Muscle; 2021 Oct; 12(5):1189-1202. PubMed ID: 34448539
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the prognostic value of ECOG-PS, mGPS and BMI/WL: Implications for a clinically important framework in the assessment and treatment of advanced cancer.
Dolan RD; Daly L; Sim WMJ; Fallon M; Ryan A; McMillan DC; Laird BJ
Clin Nutr; 2020 Sep; 39(9):2889-2895. PubMed ID: 31926762
[TBL] [Abstract][Full Text] [Related]
16. Association of systemic inflammation with survival in patients with cancer cachexia: results from a multicentre cohort study.
Zhang Q; Song MM; Zhang X; Ding JS; Ruan GT; Zhang XW; Liu T; Yang M; Ge YZ; Tang M; Li XR; Qian L; Song CH; Xu HX; Shi HP
J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1466-1476. PubMed ID: 34337882
[TBL] [Abstract][Full Text] [Related]
17. Near-term prognostic impact of integrated muscle mass and function in upper gastrointestinal cancer.
Tang M; Ge Y; Zhang Q; Zhang X; Xiao C; Li Q; Zhang X; Zhang K; Song M; Wang X; Yang M; Ruan G; Mu Y; Huang H; Cong M; Zhou F; Shi H
Clin Nutr; 2021 Sep; 40(9):5169-5179. PubMed ID: 34461591
[TBL] [Abstract][Full Text] [Related]
18. Change in neutrophil to lymphocyte ratio during immunotherapy treatment is a non-linear predictor of patient outcomes in advanced cancers.
Li M; Spakowicz D; Burkart J; Patel S; Husain M; He K; Bertino EM; Shields PG; Carbone DP; Verschraegen CF; Presley CJ; Otterson GA; Kendra K; Owen DH
J Cancer Res Clin Oncol; 2019 Oct; 145(10):2541-2546. PubMed ID: 31367835
[TBL] [Abstract][Full Text] [Related]
19. Hand grip strength-based cachexia index as a predictor of cancer cachexia and prognosis in patients with cancer.
Xie H; Ruan G; Wei L; Zhang H; Ge Y; Zhang Q; Lin S; Song M; Zhang X; Liu X; Li X; Zhang K; Yang M; Tang M; Song CH; Gan J; Shi HP
J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):382-390. PubMed ID: 36447437
[TBL] [Abstract][Full Text] [Related]
20. Modified Controlling Nutritional Status (mCONUT) serves as a promising prognostic factor in patients with cancer cachexia.
Zhang X; Huang JX; Tang M; Zhang Q; Deng L; Song CH; Li W; Shi HP; Cong MH
Nutrition; 2024 Jan; 117():112229. PubMed ID: 37922740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
